Virtual Tumor Board: Relapsed SCLC
Podcast | English | 49 Min
Image For Activity Cover
No Credit Offered

In this episode of Lung Cancer Considered, host Dr. Stephen Liu discusses the management of small cell lung cancer using a virtual tumor board format. SCLC is an aggressive subtype of lung cancer, and for patients with advanced or extensive-stage disease, the current first-line standard of care is chemo-immunotherapy. For those who do not achieve long-term disease control, second-line options are somewhat limited. Dr. Liu, Dr. Blackhall, and Dr. Shields discuss currently available treatment options (platinum-retreatment, lurbinectedin, topotecan) and some promising drugs in development for SCLC.

Podcast Host:
  • Stephen Liu, MD, Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics, Georgetown Lombardi Comprehensive Cancer Center, USA 

Podcast Guests: 

  • Fiona Blackhall, PhD, FRCP, Professor and Chair of Thoracic Oncology, University of Manchester; Director of Research & Innovation at the Christie Foundation NHS Trust, UK
  • Misty Shields, MD, PhD, Assistant Professor, Indiana University, IASLC Fellowship Grant Recipient
Powered By